HemosIL PT reagents offer consistent performance sensitivity to allow optimal monitoring of oral anticoagulant therapy and assessment of the extrinsic coagulation pathway. Highly stable and consistently consistent for moderate to high sensitivity. HemosIL APTT reagents allow optimal monitoring of therapeutic coagulation inhibitors and screening of the intrinsic coagulation pathway. The general screening panel also includes fibrinogen tests to assess bleeding risk in patients with unexplained prolonged PT or APTT results.

Consistency, test after test, for optimal efficiency .